Khanna Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.49 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.70 Cr
- Revenue Growth -9.45%
- Profit Growth -96.67%
- Ebitda -54.67%
- Net Worth 1.32%
- Total Assets 2.37%
About Khanna Diagnostics
Khanna Diagnostics Private Limited (KDPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 2019 (Five years and four months 13 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Corporate was formerly known as Khanna Diagonstics Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.49 M.
The company currently has active open charges totaling ₹6.70 Cr.
Sangeeta Khanna and Atul Khanna serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100UP2019PTC122334
- Company No.
122334
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Khanna Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sangeeta Khanna  | Whole-Time Director | 15-Oct-2019 | Current |
| Atul Khanna | Whole-Time Director | 15-Oct-2019 | Current |
Financial Performance of Khanna Diagnostics.
Khanna Diagnostics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.45% decrease. The company also saw a substantial fall in profitability, with a 96.67% decrease in profit. The company's net worth moved up by a moderate rise of 1.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Khanna Diagnostics?
In 2023, Khanna Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹67.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 6.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2023 | Hdfc Bank Limited | ₹5.22 Cr | Open |
| 04 Oct 2022 | Hdfc Bank Limited | ₹4.00 M | Open |
| 16 Jul 2021 | Hdfc Bank Limited | ₹9.50 M | Open |
| 24 Jun 2021 | Hdfc Bank Limited | ₹1.30 M | Open |
How Many Employees Work at Khanna Diagnostics?
Khanna Diagnostics has a workforce of 54 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Khanna Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Khanna Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.